Definitive Contract W81XWH22C0005
Award Date
9/9/22
Potential Completion Date
9/8/25
Potential Value
$2.9M
Federal Agency
Defense Health Agency
Awardee
Neomatrix Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price Level of Effort
Place of Performance
Stony Brook, NY 11790, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $1,986,378 Definitive Contract to Synedgen, Inc., a small business prime contractor, to conduct Phase II Small Business Innovation Research (SBIR) efforts for the development of technologies to control scar formation after burn injuries. The contract is designated as a Total Small Business set-aside and has an ultimate completion date of April 1, 2023. Synedgen, a for-profit manufacturer with expertise in regenerative medicine...
This is a $1,632,483.31 Firm Fixed Price Definitive Contract awarded by the Defense Health Agency (DHA) to Spectral MD, Inc., a small business technology company specializing in wound imaging and assessment using artificial intelligence (AI). The contract is for the "Development of Device to Enable the Assessment of Burn Severity by Artificial Intelligence in the Military's Echelon III Care Environment" under the Small Business Technology Transfer (STTR) program. It is a follow-on...
This is a $173,159,357.00 cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Mediwound LTD, a for-profit manufacturer located in Israel. The contract is for thermal burn debridement products and services, with a period of performance through September 27, 2025. This contract does not have a set-aside designation. The agency that awarded this contract, ASPR, is responsible for leading the...
This is a $1,249,624 firm fixed-price purchase order contract awarded to Gelsana Therapeutics Inc., a woman-owned small business and HUBZone certified corporation, by the Air Force Research Laboratory (AFRL) under the Small Business Innovation Research (SBIR) Program. The contract is for the development of novel zwitterionic hydrogels to enhance wound healing in combat-related burn injuries. This is the Phase II award, building on a previous Phase I contract valued at $74,950. The contract has a...
<p>This is a $249,820.14 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Paranano Wound Care LLC, a small business, under the Department of Defense's Broad Agency Announcement (BAA) 2022.2 SBIR Phase I program. The contract is for the purpose of demonstrating a technology for the early detection and monitoring of wound infections. This award is not associated with a larger contract vehicle. The contract has a small business set-aside designation.</p>
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $39,077,589.00 cost-plus-fixed-fee definitive contract to Mediwound LTD, a for-profit manufacturer located in Israel. The contract, which is not set-aside, has an ultimate completion date of October 1, 2026. The contract award does not appear to be associated with a larger contracting vehicle. The contract requires the delivery of products or services, though...
The National Cancer Institute (NCI) awarded a $196,707 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Synedgen, Inc., a for-profit manufacturer, to conduct research and development for biomedical basic research. The contract was designated as a Total Small Business set-aside. Through this SBIR Phase I award, Synedgen will advance scientific knowledge and technologies to control scar formation after burn injuries, leveraging its expertise in regenerative medicine...
<p>This is a firm fixed-price contract awarded by the U.S. Army Medical Command (MEDCOM) to Nanoderm Sciences, Inc., a small business, for a SBIR (Small Business Innovation Research) Phase I project. The contract has a ceiling value of $149,837.83 and a completion date of April 27, 2016. The contract is for research and development under the SBIR program, but the specific details of the products or services being delivered are not provided in the information given.</p>
This contract was awarded by the Department of the Army Medical Command to Zetroz Systems LLC, a self-certified small disadvantaged business, to conduct research and development under the STTR Phase II program. The contract, valued at $999,979.32, is for the project "DHP PHASE II STTR ENTITLED 'INNOVATIVE WOUND REGENERATION SUPPORT APPROACHES TO ENABLE RAPID TREATMENT OF WOUNDED WARFIGHTERS'". The contract is a fixed-price level of effort definitive contract with a completion date of...
This is a $938,336.42 firm fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Icon Government And Public Health Solutions, Inc., a foreign-owned for-profit organization. The contract is for "OMNIBUS III / 03-H LABOR WOUND CARE R AND D" and has an ultimate completion date of October 31, 2021. It is not associated with a set-aside program. Icon Government And Public Health Solutions, Inc. is an experienced federal contractor, holding several...